Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease
- PMID: 20104055
- PMCID: PMC2813459
- DOI: 10.1097/JGP.0b013e3181b208ef
Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease
Abstract
Objective: Elderly patients with cardiovascular disease (CVD) often report cognitive difficulties including reduced cognitive processing speed and attention. On cross-sectional examination, such reports relate more closely to mood than to objective measures of cognitive performance, thus questioning the validity of subjective cognitive complaints as a marker of neurodegenerative processes. This study examined the longitudinal relationship among self-reported cognitive difficulties, depression, and performance on objective tests of global cognition in patients with CVD.
Participants and methods: Forty-seven patients with CVD (aged 55-85 years) completed a measure of perceived cognitive dysfunction (Cognitive Difficulties Scale [CDS]), a medical history questionnaire, the Dementia Rating Scale (DRS), and the Beck Depression Inventory (BDI) at baseline and 12 months later. Baseline brain imaging was available on a small subsample (N = 17).
Results: Hierarchical linear regression revealed that increased report of cognitive difficulties at baseline was significantly associated with poorer DRS performance at follow-up (F[3, 43] = 4.45, p = 0.008, CDS partial r = -0.30, p = 0.048), independent of age, education, baseline DRS, and BDI scores. Greater perceived cognitive dysfunction at baseline also related to higher level of white matter lesions (r = 0.53, df = 15, p = 0.028).
Conclusions: Self-reported cognitive difficulties may reflect early changes in cognitive aging that are difficult to detect using global cognitive screening measures at a single time point. However, these perceived difficulties relate to objectively measured cognitive decline over time. Thus, they may provide important clinical information about early neurodegenerative processes that should be carefully monitored.
Figures




Similar articles
-
Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure.J Cardiovasc Nurs. 2009 May-Jun;24(3):192-7. doi: 10.1097/JCN.0b013e31819b54de. J Cardiovasc Nurs. 2009. PMID: 19390336 Free PMC article.
-
Functional magnetic resonance imaging of working memory reveals frontal hypoactivation in middle-aged adults with cognitive complaints.J Int Neuropsychol Soc. 2011 Sep;17(5):915-24. doi: 10.1017/S1355617711000956. J Int Neuropsychol Soc. 2011. PMID: 21880172
-
Demographic, neuropsychological, and functional predictors of rate of longitudinal cognitive decline in Hispanic older adults.Am J Geriatr Psychiatry. 2011 May;19(5):440-50. doi: 10.1097/JGP.0b013e3181e9b9a5. Am J Geriatr Psychiatry. 2011. PMID: 20808135 Free PMC article.
-
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.Alzheimers Res Ther. 2019 Jul 27;11(1):64. doi: 10.1186/s13195-019-0521-0. Alzheimers Res Ther. 2019. PMID: 31351489 Free PMC article.
-
Neuroanatomical substrates of age-related cognitive decline.Psychol Bull. 2011 Sep;137(5):753-84. doi: 10.1037/a0023262. Psychol Bull. 2011. PMID: 21463028 Free PMC article. Review.
Cited by
-
Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY).Circulation. 2019 Nov 12;140(20):1626-1635. doi: 10.1161/CIRCULATIONAHA.119.041603. Epub 2019 Oct 14. Circulation. 2019. PMID: 31607143 Free PMC article. Clinical Trial.
-
Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial.BMC Geriatr. 2011 May 26;11:27. doi: 10.1186/1471-2318-11-27. BMC Geriatr. 2011. PMID: 21615936 Free PMC article. Clinical Trial.
-
Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.Ageing Res Rev. 2020 Mar;58:101022. doi: 10.1016/j.arr.2020.101022. Epub 2020 Jan 26. Ageing Res Rev. 2020. PMID: 31996326 Free PMC article. Review.
-
Utility of the cognitive difficulties scale and association with objective test performance.Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):755-61. doi: 10.1177/1533317514539032. Epub 2014 Jun 13. Am J Alzheimers Dis Other Demen. 2014. PMID: 24928819 Free PMC article.
-
Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults.J Gerontol B Psychol Sci Soc Sci. 2018 Sep 20;73(7):1198-1202. doi: 10.1093/geronb/gbw207. J Gerontol B Psychol Sci Soc Sci. 2018. PMID: 28329816 Free PMC article.
References
-
- Glodzik-Sobanska L, Reisberg B, De Santi S, et al. Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dement Geriatr Cogn Disord. 2007;24:177–184. - PubMed
-
- Jorm AF, Christensen H, Korten AE, et al. Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7–8 years. Psychol Med. 2001;31:441–449. - PubMed
-
- Gallassi R, Bisulli A, Oppi F, et al. Subjective cognitive complaints, neuropsychological performance, affective and behavioural symptoms in non-demented patients. Int J Geriatr Psychiatry. 2008;23:95–101. - PubMed
-
- Tobiansky R, Blizard R, Livingston G, et al. The Gospel Oak Study stage IV: the clinical relevance of subjective memory impairment in older people. Psychol Med. 1995;25:779–786. - PubMed
-
- Dufouil C, Fuhrer R, Alperovitch A. Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study. J Am Geriatr Soc. 2005;53:616–621. - PubMed
Publication types
MeSH terms
Grants and funding
- AG020498/AG/NIA NIH HHS/United States
- P30-AG013846/AG/NIA NIH HHS/United States
- MH065857/MH/NIMH NIH HHS/United States
- AG017975/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- HL074568/HL/NHLBI NIH HHS/United States
- F32 AG026850/AG/NIA NIH HHS/United States
- K23 MH065857/MH/NIMH NIH HHS/United States
- R01 AG017975/AG/NIA NIH HHS/United States
- K23 AG030962/AG/NIA NIH HHS/United States
- T32 AG020498/AG/NIA NIH HHS/United States
- R01 NS052470/NS/NINDS NIH HHS/United States
- K23-AG030962/AG/NIA NIH HHS/United States
- 5R01NS052470/NS/NINDS NIH HHS/United States
- AG026850/AG/NIA NIH HHS/United States
- F32 HL074568/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous